Navigation Links
Law Offices of Howard G. Smith Announces Class Action Lawsuit Against LCA-Vision Inc.
Date:9/17/2007

BENSALEM, Penn., Sept. 17 /PRNewswire/ -- Law Offices of Howard G. Smith announces that a securities class action lawsuit has been filed on behalf of shareholders who purchased the common stock of LCA-Vision Inc. ("LCA-Vision" or the "Company") (Nasdaq: LCAV) between February 12, 2007 and July 30, 2007 (the "Class Period"). The class action lawsuit was filed in the United States District Court for the Southern District of Ohio.

The Complaint alleges that defendants violated federal securities laws by issuing material misrepresentations to the market concerning the Company's business and financial performance, thereby artificially inflating the price of LCA-Vision securities.

No class has yet been certified in the above action. Until a class is certified, you are not represented by counsel unless you retain one. If you purchased LCA-Vision shares between February 12, 2007 and July 30, 2007, you have certain rights, and have until November 12, 2007, to move for Lead Plaintiff status. To be a member of the class you need not take any action at this time, and you may retain counsel of your choice. If you wish to discuss this action or have any questions concerning this Notice or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215)638-4847, Toll-Free at (888)638-4847, by email to howardsmithlaw@hotmail.com or visit our website at http://www.howardsmithlaw.com.


'/>"/>
SOURCE Law Offices of Howard G. Smith
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Gigantic Effort: Smoking To Be Banned in British Telecom’s Offices and Van
2. Smoking to be Prohibited at Public Offices in Bangkok from 2008
3. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
4. Iodex goes to SmithKline Beecham consumer Healthcare
5. GlaxoSmithKline To Cultivate Non-Smoking Environment
6. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
7. FDA Mislead On Asthma Drug By GlaxoSmithKline
8. GlaxoSmithKline Defends Its Products
9. GlaxoSmithKline launches diabetes and cancer drugs
10. Generic Products Compete With GlaxoSmithKline
11. New Cervical Cancer Vaccine to Be Launched By Glaxo Smithkline

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...e patient outcomes, research suggests , ,...ation drug therapy shows promise in treating patie...rs say. , The study from the Massachusetts Gene...rvival and tumor response in patients treated with...that has helped slow the growth of other cancers, ...
(Date:11/23/2009)... get sick, study finds , , MONDAY, Nov. ...netic variation appears to play a major role in sl.... , In fact, those with the variation appear ...mplications of the disease. , "We,re honing i...e a person more or less susceptible to HIV, in ter...
(Date:11/23/2009)...23/PRNewswire/--HealthLeaders-InterStudy,aleadingp...self-insuredmembercompaniesthatarepartofMilwaukee,...healthcare-costdecreaseof1.5percentperhealthplanme...formanceprovidernetwork.Accordingtothe MilwaukeeMa...mbercompaniessaved$44millioninhealthcarecostsovert...
(Date:11/23/2009)...re-FirstCall/-- ,, DearIsisSupportersandShareho...continuingsupportofIsis.Webelieveweareatoneofthemo...ofthebeginningofcreatingauniquecompanywithanoveldr...heissueshauntingthepharmaceuticalindustry. ,, O...agshipdrug,mipomersen.Mipomersencontinuestoperform...
(Date:11/23/2009)...erylCompanies,thenation,sleadingproviderofoutsourc...rnedrecognitionasoneofthetopoutsourcingfirmsinheal...demagazine.Berylwasrankedamongthepublication,stop2...,whichenabledittoclimbfromtwelfthplacein2007totent...tiveproducts,suchasitsnewestlaunchofpost-discharge...
Breaking Medicine News(10 mins):Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2Health News:Genetic Variant Slows AIDS Progression 2Health News:Milwaukee Employers See Cost Savings with High-Performance Provider Network 2Health News:The Beryl Companies Named One of the 'Top 10 Outsourcing Firms' in Healthcare 2
..., PhD, FNP Join Together to Raise Awareness of Com... , ANAHEIM, Calif., May 12 Fibromyalgia is often...who have it typically do not look sick. However, ...e U.S., affecting more than five million Americans...
...e.com, Recommended to Help Guide Important Convers...nosis , , NEW YORK, May 12 The multi-disciplina...ase Screening Discussion Group (ADSDG) is calling ...,s disease (AD) symptoms. The goal of the call-to-...
...nce, Biomarker Strategies and Pharma on Panel , ,...nc. (NYSE Amex: ILI ) announced today that CEO L...l discussion titled "Integrating Genetic Markers i...anta, GA. The panel discussion will be held Tuesd...
... Inc., the leading provider of pathway data minin...ion, the premiere visualization and analysis softw...a, today announced the integration of the MetaCore...tion will benefit," said Julie Bryant, VP of Busin...
...he rating agency,Standard & Poor,s has today c...eimer Group and continues to categorize the outloo...pharma & life science industry is therefore,as...urope,America and Asia. In the financial year 2008...
...emier medical and surgical equipment supplier, now...nt monitors that feature clinically-proven techno... , (Vocus) May 12, 2009 --...de the DRE ASM 6000 and DRE ASM 6000 Pro, sleek pa...
Other Medicine News:Health News:VIDEO from Medialink, the National Fibromyalgia Association and Pfizer: The Painful Truth about Fibromyalgia 2Health News:Experts Urge Family Members and Friends to Seek Immediate Intervention for Their Loved Ones Who May Have Alzheimer's Disease (AD) 2Health News:Experts Urge Family Members and Friends to Seek Immediate Intervention for Their Loved Ones Who May Have Alzheimer's Disease (AD) 3Health News:Experts Urge Family Members and Friends to Seek Immediate Intervention for Their Loved Ones Who May Have Alzheimer's Disease (AD) 4Health News:Experts Urge Family Members and Friends to Seek Immediate Intervention for Their Loved Ones Who May Have Alzheimer's Disease (AD) 5Health News:Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention 2Health News:Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention 3Health News:GeneGo and OmicSoft Announce Integration 2Health News:GeneGo and OmicSoft Announce Integration 3Health News:DRE Medical Equipment Releases New Multi-Function Patient Monitors 2
(Date:11/23/2009)...tCall/--CordBloodAmerica,Inc.(OTCBulletinBoard:CBA...y( http://www.cordblood-america.com )focusedonbrin...nsurancepolicy,tofamiliesnationwideandinternationa...thCEOandco-founderMatthewSchisslerisnowavailable. ...2875811 . ,, Intheinterview,Mr.Schisslerupdates...
(Date:11/23/2009)...-FirstCall/--RaptorPharmaceuticalCorp.("Raptor"ort...tationofclinicaltrialdataonNGX426,theCompany,soral...gonist,atthe12thInternationalConferenceontheMechan...-21inSanFrancisco.TheresultsofthestudyledbyMarkWal...nterforPainMedicineoftheUniversityofCaliforniaatSa...
(Date:11/23/2009)...wire-FirstCall/--Oceanside Pharmaceuticals ,partof...todayannouncedthatithasnowlaunchedchlordiazepoxide...ic(AG)versionofLibrax®.Oceansidehasreceivedit...ibrax®genericmarket. ,, "Valeant,sOceansid...withitssuccessfullaunchanddistributionof5%fluorour...
Breaking Medicine Technology:Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5Oceanside Pharmaceuticals Announces Launch of Librax(R) AG 2Avaxia Biologics Awarded Phase I SBIR Grant to Develop Antibody Therapeutic for Oral Mucositis 14091 1Avaxia Biologics Awarded Phase I SBIR Grant to Develop Antibody Therapeutic for Oral Mucositis 14091 2Avaxia Biologics Awarded Phase I SBIR Grant to Develop Antibody Therapeutic for Oral Mucositis 14091 3 Evaluation of standard liver volume formula for Chinese adults 57348 1HBV genotype B B3 and C C1 are the major genotypes in Indonesia 3F 57345 1
...n Evolve Student Journalism Award, PRINCETON, N.J...and the NSRC,s Campaign for Sexual Literacy are no...e Student Journalism Award.,The award will recogni...eporting on sexual health topics in their college ...U.S. can apply by submitting an article,published ...
...icals,Inc. (Amex: IMM ) announced that the presen...eeting will be posted on the Company,s website, ht..., About Immtech Pharmaceuticals, Inc., Immtech P...commercializing drugs to treat infectious diseases...ude new treatments for Pneumocystis pneumonia,(PCP...
Other Medicine Technology:Trojan(R) and the National Sexuality Resource Center's Campaign for Sexual Literacy Recognize Outstanding College Reporting on Sexual Health 2Trojan(R) and the National Sexuality Resource Center's Campaign for Sexual Literacy Recognize Outstanding College Reporting on Sexual Health 3Trojan(R) and the National Sexuality Resource Center's Campaign for Sexual Literacy Recognize Outstanding College Reporting on Sexual Health 4Immtech Announces Posting of Annual Shareholders Meeting Presentation 2
Disposable Caps and Plugs
Bivona® Uncuffed Pediatric FlexTend™ Plus Standard Tracheostomy Tubes
Bivona® TTS™ Cuffed Pediatric Tracheostomy Tubes
Portex® Extra Length Pediatric Tracheostomy Tubes with 15 mm Connector
Medicine Products: